Status:
RECRUITING
Genetic Newborn Screening for Cystinosis and Primary Hyperoxaluria
Lead Sponsor:
Cystinose Stiftung
Collaborating Sponsors:
Screening Laboratory Hannover
Pediatry Kastanienhof Koeln
Conditions:
Cystinosis
Primary Hyperoxaluria
Eligibility:
All Genders
32-72 years
Phase:
NA
Brief Summary
In Germany parents of newborns are offered newborn screening (NBS) for 17 congenital diseases as a standard benefit of statutory health insurance. NBS in Germany is voluntary. Cystinosis and hyperoxal...
Detailed Description
Background and aims. Population-based newborn screening (NBS) is an important public health program that has vastly improved the course of several diseases through early detection. The selection of sc...
Eligibility Criteria
Inclusion Criteria:
- Newborns participating at the NGS with parent's consent to participate in this screening project
Exclusion Criteria:
- Newborns without parent's consent to participate in this screening project.
Key Trial Info
Start Date :
March 15 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2026
Estimated Enrollment :
200000 Patients enrolled
Trial Details
Trial ID
NCT05843851
Start Date
March 15 2022
End Date
June 30 2026
Last Update
May 6 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Screening Laboratory Hanover
Hanover, Lower Saxony, Germany, 30430